ABOUT HEMGENIX

Quantity of eligible individuals: CDEC mentioned the uncertainty in the amount of sufferers with moderately extreme to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some sufferers who're categorized as getting mild or average sickness could possibly have a critical ble